224 related articles for article (PubMed ID: 21815111)
41. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance.
Roy R; Gordon LI
J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969
[TBL] [Abstract][Full Text] [Related]
42. Rituximab maintenance or retreatment after autologous transplantation for relapsed follicular lymphoma?
Fozza C
J Clin Oncol; 2013 Oct; 31(30):3846-7. PubMed ID: 24062390
[No Abstract] [Full Text] [Related]
43. Advanced-stage follicular lymphoma in the rituximab era: when should patients receive anthracycline-based chemotherapy?
Pettengell R
Drugs; 2009; 69(13):1727-37. PubMed ID: 19719330
[TBL] [Abstract][Full Text] [Related]
44. What is the role of stem-cell transplantation for follicular non-hodgkin lymphoma in the rituximab era?
Schouten HC
J Clin Oncol; 2013 May; 31(13):1617-8. PubMed ID: 23547074
[No Abstract] [Full Text] [Related]
45. [Therapy of follicular lymphoma].
Buske C; Unterhalt M; Hiddeman W
Internist (Berl); 2007 Apr; 48(4):372-81. PubMed ID: 17287964
[TBL] [Abstract][Full Text] [Related]
46. Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.
Witzig TE; Flinn IW; Gordon LI; Emmanouilides C; Czuczman MS; Saleh MN; Cripe L; Wiseman G; Olejnik T; Multani PS; White CA
J Clin Oncol; 2002 Aug; 20(15):3262-9. PubMed ID: 12149300
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.
Tam CS; Herschtal A; Dickinson M; George A; Seymour JF
J Clin Oncol; 2013 Sep; 31(25):3166-7. PubMed ID: 23918946
[No Abstract] [Full Text] [Related]
48. Non-Hodgkin's lymphomas, version 2.2014.
Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Bellam N; Byrd JC; Czuczman MS; Fayad LE; Fisher RI; Glenn MJ; Harris NL; Hoppe RT; Horwitz SM; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Sokol L; Swinnen LJ; Tsien C; Vose JM; Yahalom J; Zafar N; Dwyer M; Sundar H
J Natl Compr Canc Netw; 2014 Jun; 12(6):916-46. PubMed ID: 24925202
[TBL] [Abstract][Full Text] [Related]
49. Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.
Hainsworth JD; Greco FA; Raefsky EL; Thompson DS; Lunin S; Reeves J; White L; Quinn R; DeBusk LM; Flinn IW
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):277-83. PubMed ID: 24679633
[TBL] [Abstract][Full Text] [Related]
50. Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.
Berinstein NL; Bhella S; Pennell NM; Cheung MC; Imrie KR; Spaner DE; Milliken V; Zhang L; Hewitt K; Boudreau A; Reis MD; Chesney A; Good D; Ghorab Z; Hicks LK; Piliotis E; Buckstein R
Ann Hematol; 2015 May; 94(5):813-23. PubMed ID: 25567231
[TBL] [Abstract][Full Text] [Related]
51. Treatment of follicular non-Hodgkin's lymphoma: the old and the new.
Friedberg JW
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S2-6. PubMed ID: 18760706
[TBL] [Abstract][Full Text] [Related]
52. Preface on follicular non-Hodgkin's lymphoma.
Hagenbeek A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):93. PubMed ID: 21658610
[No Abstract] [Full Text] [Related]
53. Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.
Buchegger F; Larson SM; Mach JP; Chalandon Y; Dietrich PY; Cairoli A; Prior JO; Romero P; Speiser DE
Clin Dev Immunol; 2013; 2013():875343. PubMed ID: 24371449
[TBL] [Abstract][Full Text] [Related]
54. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
Cohen JB; Kahl BS
Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
[TBL] [Abstract][Full Text] [Related]
55. Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activated.
Fisher RI; Khan N
J Natl Compr Canc Netw; 2015 Mar; 13(3):363-6. PubMed ID: 25736011
[TBL] [Abstract][Full Text] [Related]
56. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
McLaughlin P
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S91-5. PubMed ID: 22035757
[TBL] [Abstract][Full Text] [Related]
57. Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.
Helbig G; Krawczyk-Kulis M; Kopinska A; Liwoch R; Kyrcz-Krzemien S
Med Oncol; 2014 Dec; 31(12):310. PubMed ID: 25373321
[TBL] [Abstract][Full Text] [Related]
58. Radioimmunotherapy in follicular lymphoma.
Illidge T; Morschhauser F
Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
[TBL] [Abstract][Full Text] [Related]
59. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
Jacobson CA; Freedman AS
Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
[TBL] [Abstract][Full Text] [Related]
60. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
